Casdin Capital, LLC Biolife Solutions Inc Transaction History
Casdin Capital, LLC
- $1.16 Billion
- Q2 2024
A detailed history of Casdin Capital, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Casdin Capital, LLC holds 8,707,165 shares of BLFS stock, worth $210 Million. This represents 16.09% of its overall portfolio holdings.
Number of Shares
8,707,165
Previous 8,707,165
-0.0%
Holding current value
$210 Million
Previous $187 Million
-0.0%
% of portfolio
16.09%
Previous 16.16%
Shares
13 transactions
Others Institutions Holding BLFS
# of Institutions
179Shares Held
46.3MCall Options Held
11.6KPut Options Held
800-
Black Rock Inc. New York, NY5.49MShares$132 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.32MShares$79.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.79MShares$67.1 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$38 Million0.17% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.57MShares$37.8 Million0.09% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.03B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...